Cargando…
Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension
The coronavirus disease (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now spread to >200 countries posing a global public health concern. Patients with comorbidity, such as hypertension suffer more severe infection with elevated mortality. The dev...
Autores principales: | Zhang, Lei-Ke, Sun, Yuan, Zeng, Haolong, Wang, Qingxing, Jiang, Xiaming, Shang, Wei-Juan, Wu, Yan, Li, Shufen, Zhang, Yu-Lan, Hao, Zhao-Nian, Chen, Hongbo, Jin, Runming, Liu, Wei, Li, Hao, Peng, Ke, Xiao, Gengfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752915/ https://www.ncbi.nlm.nih.gov/pubmed/33349633 http://dx.doi.org/10.1038/s41421-020-00235-0 |
Ejemplares similares
-
Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension
por: Zhang, Lei-Ke, et al.
Publicado: (2021) -
Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008) -
Stability Indicating RP-HPLC Estimation of Atorvastatin Calcium and Amlodipine Besylate in Pharmaceutical Formulations
por: Shah, D. A., et al.
Publicado: (2008) -
Formulation and Evaluation of S-(-)-Amlodipine Besylate and Nebivolol Hydrochloride Tablets
por: Shaikh, S.A, et al.
Publicado: (2010) -
Chronic unilateral chemosis following the use of amlodipine besylate
por: Kim, Kyeong Hwan, et al.
Publicado: (2014)